Back to search

University of Leeds

Improving gene activated matrices for orthopaedic bone regeneration: alternative biomaterials and predicted mRNA structure based BMP2 signal peptide optimisation

Abstract

dc:description.abstract

Critical and non-union defects are bone injuries that will not fully heal spontaneously, with existing treatments frequently unable to improve outcomes. These defects represent an increasing burden on health systems world-wide and there is an unmet clinical need for improved treatments. Gene-activated matrices (GAMs) combine a biomaterial and a gene therapy, attempting to improve performance by providing multiple osteogenic stimuli simultaneously. This project aims to develop a GAM from a self-assembling peptide (SAP) P11-4 with known hard tissue regeneration capabilities and plasmid vectors encoding the osteogenic growth factor bone morphogenetic protein 2 (BMP2), resulting in an injectable GAM that promotes a multifaceted approach to osteogenesis. New reporter vectors were created and transfection optimisation experiments performed to facilitate the P11-4 GAM work. Transfection from P11-4 GAMs proved difficult and several experiments investigating vector polyplex size and hydrogel porosity were performed to elucidate the mechanisms. A cross-linked gelatine cryogel was then developed as a passive scaffold to allow continued assessment of the plasmid vectors, demonstrating suitable porosity, sterility and biocompatibility. An in silico signal peptide (SP) screening approach based on predicted mRNA structure was designed to identify new SPs to improve BMP2 secretion. SPs from the TGF-β superfamily were screened, with the top five candidates and two controls taken forward to in vitro testing in two cell lines. The approach showed weak predictive power in one line, but none of the tested sequences were able to induce a significant increase in BMP2 secretion or induce osteogenesis. These results suggest that substantial further work would be required to create a P11-4-based GAM, the results presented here indicate that porosity and bioactivity are particularly important. The in silico SP optimisation approach successfully identified several SPs never before used for SP optimisation, but required improvement to generate biologically significant predictions.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wilkinson, Piers
Advisors dc:contributor.advisor
  • Davies, Robert Philip
  • Jackson, Brian
  • Fermor, Hazel
  • Wood, David
  • Giannoudis, Peter
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Dc Identifier Grantnumber
EP/L014823/1

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Wilkinson, Piers. Improving gene activated matrices for orthopaedic bone regeneration: alternative biomaterials and predicted mRNA structure based BMP2 signal peptide optimisation. doctoral thesis, University of Leeds, 2024.